Flubromazepam is a synthetic benzodiazepine derivative primarily encountered in analytical and forensic research contexts. Structurally classified as a triazolobenzodiazepine, it features both bromine and fluorine substitutions, contributing to its long-acting pharmacological profile. Flubromazepam acts as a positive allosteric modulator of the GABA-A receptor, consistent with compounds in the benzodiazepine class.
This compound is not approved for medical or veterinary use and is supplied strictly as a laboratory research reference material. It is commonly utilized for analytical method development, compound identification, and forensic or toxicological studies. Due to its extended half-life, flubromazepam has been of interest in comparative benzodiazepine research.
Legal classification varies internationally, and purchasers are responsible for compliance with all local laws and regulations. This product is intended exclusively for non-human, in-vitro research purposes.
Safety & Handling (MSDS-Style Summary)
-
Hazard Classification: Research chemical; CNS-active benzodiazepine
-
Handling: Use appropriate laboratory PPE
-
Storage: Store in a cool, dry, light-protected environment
-
Disposal: Dispose according to institutional and regulatory guidelines
